| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,315 |
9,288 |
$530K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,571 |
3,197 |
$198K |
| 87428 |
|
3,513 |
3,251 |
$195K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,509 |
4,156 |
$160K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,100 |
2,322 |
$40K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
604 |
574 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,268 |
3,044 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,444 |
1,157 |
$31K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
979 |
739 |
$26K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
640 |
581 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,053 |
1,872 |
$2K |
| H0033 |
Oral medication administration, direct observation |
343 |
328 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
174 |
163 |
$344.05 |
| 81002 |
|
27 |
26 |
$63.56 |
| 4120F |
|
3,650 |
3,397 |
$0.00 |
| 1159F |
|
7,358 |
6,760 |
$0.00 |
| 4135F |
|
1,142 |
1,079 |
$0.00 |
| 3210F |
|
1,479 |
1,395 |
$0.00 |
| 3078F |
|
4,796 |
4,417 |
$0.00 |
| 3077F |
|
118 |
108 |
$0.00 |
| 4133F |
|
901 |
854 |
$0.00 |
| 4016F |
|
4,129 |
3,853 |
$0.00 |
| 2001F |
|
7,910 |
7,272 |
$0.00 |
| 3074F |
|
5,790 |
5,338 |
$0.00 |
| 3079F |
|
351 |
330 |
$0.00 |
| 3008F |
|
2,858 |
2,595 |
$0.00 |
| 4450F |
|
269 |
261 |
$0.00 |
| 3080F |
|
49 |
47 |
$0.00 |
| 3075F |
|
14 |
13 |
$0.00 |